Trademark Attorney / Law Firm
JOHN M SCAGNELLI – Trademark Portfolio
JOHN M SCAGNELLI specializes in Class 5 (Pharmaceuticals) trademark filings before the United States Patent and Trademark Office (USPTO), with 14 of 22 total filings concentrated in this category. The practice also covers Class 35 (Advertising & Business) along with 3 other Nice Classification classes. Filing activity spans from 1997 to 2019. Currently, 5 trademarks are registered.
Showing of trademarks Trademarks
Practice Areas by Trademark Class
JOHN M SCAGNELLI's trademark practice covers 3 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademark applications has JOHN M SCAGNELLI filed?
JOHN M SCAGNELLI has filed 22 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 5 registered, 7 abandoned, 10 cancelled.
What trademark classes does JOHN M SCAGNELLI specialize in?
JOHN M SCAGNELLI has filed trademarks across 3 Nice Classification classes. The most common practice areas include Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
How long has JOHN M SCAGNELLI been filing trademarks?
JOHN M SCAGNELLI's trademark filing history with the USPTO spans from 1997 to 2019, covering 22 years of trademark practice. During this period, JOHN M SCAGNELLI has handled 22 trademark applications.
What is JOHN M SCAGNELLI's trademark registration success rate?
JOHN M SCAGNELLI has a 23% trademark registration rate, with 5 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.